Literature DB >> 7875741

Differential effects of chlorination of bacteria on their capacity to generate NO, TNF-alpha and IL-6 in macrophages.

J Marcinkiewicz1, B Czajkowska, A Grabowska, A Kasprowicz, B Kociszewska.   

Abstract

Activated rodent macrophages produce high amounts of nitric oxide (NO). NO as a tumoricidal and defence molecule against intracellular parasites is commonly accepted. However, its role as an obligatory killing factor for extracellular bacteria is controversial. In the present study we stimulated murine peritoneal macrophages by heat-killed bacteria (Staphylococcus aureus, S. epidermidis and Escherichia coli). In some groups bacteria were pretreated with HOCl, to replace the chlorinating system in activated neutrophils that operates as a bactericidal system in vivo. High levels of NO, tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) were detected after stimulation by all non-chlorinated bacteria strains tested. However, after chlorination Gram-positive bacteria lost their ability to induce NO and TNF-alpha, whereas phagocytosis and IL-6 production were not affected by chlorination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7875741      PMCID: PMC1415071     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

Review 1.  Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens.

Authors:  S J Green; C A Nacy; M S Meltzer
Journal:  J Leukoc Biol       Date:  1991-07       Impact factor: 4.962

2.  Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G.

Authors:  C W Cutler; J R Kalmar; R R Arnold
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 3.  Role of nitric oxide synthesis in macrophage antimicrobial activity.

Authors:  C F Nathan; J B Hibbs
Journal:  Curr Opin Immunol       Date:  1991-02       Impact factor: 7.486

4.  Enhancement of immunogenic properties of ovalbumin as a result of its chlorination.

Authors:  J Marcinkiewicz; B M Chain; E Olszowska; S Olszowski; J M Zgliczyński
Journal:  Int J Biochem       Date:  1991

Review 5.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

6.  Nitric oxide-mediated apoptosis in murine peritoneal macrophages.

Authors:  J E Albina; S Cui; R B Mateo; J S Reichner
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

7.  Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes.

Authors:  S J Klebanoff; C B Hamon
Journal:  J Reticuloendothel Soc       Date:  1972-08

8.  The interaction of macrophages and bacteria: Escherichia coli species, bacterial lipopolysaccharide, and lipid A differ in their ability to induce tumoricidal activity and the secretion of reactive nitrogen intermediates in macrophages.

Authors:  R Keller; R Gehri; R Keist
Journal:  Cell Immunol       Date:  1992-04-15       Impact factor: 4.868

9.  L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes.

Authors:  H W Murray; R F Teitelbaum
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

10.  In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6.

Authors:  J Marcinkiewicz
Journal:  Cytokine       Date:  1991-07       Impact factor: 3.861

View more
  2 in total

Review 1.  N-chloramines, a promising class of well-tolerated topical anti-infectives.

Authors:  Waldemar Gottardi; Dmitri Debabov; Markus Nagl
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

2.  Modulation of antigen-specific T-cell activation in vitro by taurine chloramine.

Authors:  J Marcinkiewicz; A Grabowska; B M Chain
Journal:  Immunology       Date:  1998-07       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.